Mizuho Initiates Coverage of Molecular Tools Vendors | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mizuho Securities has initiated coverage on five molecular tools firms, adding to a number of molecular diagnostics firms the investment bank began covering last month.

After the close of the market on Monday, Mizuho announced in separate reports it was covering Illumina, Life Technologies, Waters, Thermo Fisher Scientific, and Sigma-Aldrich.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.